 |
PDBsum entry 3atw
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3atw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Structure-based design, synthesis, evaluation of peptide-mimetic sars 3cl protease inhibitors
|
|
Structure:
|
 |
3c-like proteinase. Chain: a, b. Synonym: 3cl-pro, 3clp, nsp5. Engineered: yes. Mutation: yes. Peptide ace-thr-val-alc-his-h. Chain: c, d. Engineered: yes
|
|
Source:
|
 |
Sars coronavirus. Sars-cov. Organism_taxid: 227859. Gene: 1a. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: the peptide was designed and chemically synthesized.
|
|
Resolution:
|
 |
|
2.36Å
|
R-factor:
|
0.203
|
R-free:
|
0.243
|
|
|
Authors:
|
 |
K.Akaji,H.Konno,H.Mitsui,K.Teruya,Y.Hattori,T.Ozaki,M.Kusunoki, A.Sanjho
|
|
Key ref:
|
 |
K.Akaji
et al.
(2011).
Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
J Med Chem,
54,
7962-7973.
PubMed id:
|
 |
|
Date:
|
 |
|
20-Jan-11
|
Release date:
|
14-Dec-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0C6U8
(R1A_CVHSA) -
Replicase polyprotein 1a from Severe acute respiratory syndrome coronavirus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
4382 a.a.
300 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.7.50
- mRNA guanylyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 5'-end diphospho-ribonucleoside in mRNA + GTP + H+ = a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate
|
 |
 |
 |
 |
 |
5'-end diphospho-ribonucleoside in mRNA
|
+
|
GTP
|
+
|
H(+)
|
=
|
5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.4.19.12
- ubiquitinyl hydrolase 1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.4.22.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.3.4.22.69
- Sars coronavirus main proteinase.
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
54:7962-7973
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
|
|
K.Akaji,
H.Konno,
H.Mitsui,
K.Teruya,
Y.Shimamoto,
Y.Hattori,
T.Ozaki,
M.Kusunoki,
A.Sanjoh.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |